Is Neueon Towers overvalued or undervalued?
As of March 27, 2024, Neueon Towers is considered overvalued and risky due to negative financial ratios and poor performance compared to peers, despite a recent 80.21% stock return.
As of 27 March 2024, the valuation grade for Neueon Towers has moved from does not qualify to risky, indicating a significant downgrade in its investment attractiveness. The company appears to be overvalued given its negative financial ratios, including a PE ratio of -0.30, an EV to EBITDA of -969.05, and an EV to Sales ratio of 1337.29. These figures suggest that the company's financial health is in a precarious state, which is further supported by its negative return on capital employed and negative book value.When compared to peers, Neueon Towers stands out unfavorably against companies like K E C International, which has a PE ratio of 41.47, and Kalpataru Projects, with a PE of 33.47. This stark contrast highlights the overvaluation of Neueon Towers in relation to its industry. Additionally, while the stock has shown impressive returns over the past year at 80.21%, it is essential to note that this performance is not reflective of its underlying financial stability, especially when compared to the Sensex's 7.57% return over the same period. Overall, Neueon Towers is considered overvalued based on its current financial metrics and peer comparisons.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
